Windsor Creek Advisors’s Biogen BIIB Stock Holding History

Windsor Creek Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,114	Closed	-$1.3M	–	143
2018 Q4	$1.27M	Buy	+4,114	New	+$1.31M	0.4%	57

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Windsor Creek Advisors's BIIB Position: Q1 2019 in Review

Windsor Creek Advisors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 4,114 shares — an estimated $1.3M sold.

Windsor Creek Advisors first reported a position in BIIB in Q4 2018 and held it in 1 quarter. The position peaked at $1.27M in Q4 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Windsor Creek Advisors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Windsor Creek Advisors sold 4,114 Biogen shares in Q1 2019, an estimated $1.3M.
Windsor Creek Advisors first reported a position in Biogen in Q4 2018 and held it in 1 quarter.
Windsor Creek Advisors's Biogen position peaked at $1.27M in Q4 2018.
1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Windsor Creek Advisors's 13F filing for Q1 2019, filed 14 May 2019.